Eballena, Mike R.
HRN: 23-05-27 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/01/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/01/2023
06/07/2023
IV
50
Q24
Sepsis
Waiting Final Action
07/29/2023
CEFUROXIME 750MG (VIAL)
07/29/2023
08/04/2023
IV
150mg
Q8H
PCAP-C
Checking Final Appropriateness